Erectile Dysfunction Devices Market

Erectile Dysfunction Devices Market Size by Type (Vacuum Constriction Devices, Penile Implants), Source (Vascular, Neurologic disorder), End-user (Hospital, Ambulatory Surgery Center), & Region (North America, Europe, Asia) - Global Forecast to 2028

Report Code: MD 8720 Jul, 2023, by marketsandmarkets.com

The global size of erectile dysfunction devices market in terms of revenue was estimated to be worth USD 1.7 billion in 2023 and is poised to reach USD 2.7 billion by 2028, growing at a CAGR of 8.8% from 2023 to 2028. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The growth in this market is attributed to the growing prevalence of erectile dysfunction with rise in the prevalence of prostate cancer, vascular and neurological disorders. However, the high costs associated with erectile dysfunction devices restrain the growth of this market.

Attractive Opportunities in the Erectile Dysfunction Devices Market

Erectile Dysfunction Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Erectile Dysfunction Devices Market

Erectile Dysfunction Devices Market Dynamics

DRIVER: Increase in prevalence of prostate cancer

Prostate cancer treatment possesses the most common side effect for erectile dysfunction as it reduces the body’s ability to generate testosterone. Thus, low testosterone will impact one’s libido, which makes them unable to maintain an erection. According to the WHO, 209,512 patients were living with prostate cancer in the US in 2020, and this figure is projected to increase to 257,264 by 2040. Whether the nerves were spared or not at the time of surgery or whether the most precise dose planning was used or not at the time of radiation therapy, the most common side effect after the treatment is erectile dysfunction. This is due to the delicate nerve and blood vessels which control the erection that is the physical aspect, and the changes could be seen due to any kind of trauma.

RESTRAINT: Risk associated with the use of erectile dysfunction devices

The side effects of shockwave treatment include penile skin bruising, hematoma, hematuria, infection of penile skin, painful erection, and difficulty having intercourse after infection or pain. The progression of lower urinary tract symptoms (LUTS) in lieu takes place as another side effect if not taking the PDE5 inhibitor. This is because a shock wave is a kind of acoustic wave that transfers energy that can be targeted and focused non-invasively to affect a distant selected anatomic region. ESWT for ED involves applying low-intensity shock waves to the penile shaft at a specified energy setting for a predetermined number of shocks per minute and for a set treatment duration and the number of treatments.

OPPORTUNITY: Technological advancement

Advancement in technology is important for the development of more effective and user-friendly ED devices. This includes improving vacuum erection devices (VEDs), penile implants, and other device options. As erectile function issues are most common, researchers are looking into new ways constantly to treat issues such as erectile dysfunction. A new treatment that is under development is Low-intensity Shock Treatment. Extracorporeal low-intensity shockwave therapy, or LIST, involves the use of acoustic waves to generate pressure impulses, which could vascularize the tissue inside the penis and promote blood flow.

CHALLENGE: Low awareness regarding prostate health among men

Among men aged 40 years and older, prostate cancer is a common cause of morbidity and mortality. It has been shown that prostate cancer awareness plays a key role in its early detection. However, among men aged over 50 years, the awareness of prostate health is alarmingly low, according to a new survey commissioned by the European Association of Urology (despite the fact that at the age of 60 and over, 40% of men suffer from an enlarged prostate).

Erectile Dysfunction Devices Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of hyperspectral cameras and accessories. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), and Zephyr Surgical Implants (Switzerland).

Erectile Dysfunction Devices Market Ecosystem

In 2022, penile implants segment to observe the highest share of the erectile dysfunction devices industry, by type.

Based on the products, the global erectile dysfunction devices market is broadly segmented into vacuum constriction devices, penile implants, shockwave therapy, and other device types. Shockwave therapy segment to observe the highest growth rate during the forecast period. The high growth rate can be attributed to this non-invasive treatment, with no pills or medications, growing manufacturers for the shockwave devices, and increasing research for ED treatment with shockwave therapy.

In 2022, more than 60 years segment to dominate the erectile dysfunction devices industry, by age group.

Based on age group, the erectile dysfunction devices market is segmented into less than 40 years, 40–60 years, and more than 60 years. More than 60 years to dominate the market due to the increased prevalence of age related prostate cancer and CVDs in this age group which could lead to erectile dysfunction as prevalence of ED increases with age and the targeted diseases.

In 2022, North America to dominate in erectile dysfunction devices industry.

The global erectile dysfunction devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to sedentary lifestyle and a growing number of people living with diabetes and CVDs, technologically advanced devices are available, and the infrastructure of healthcare is well-established.

Erectile Dysfunction Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The erectile dysfunction devices market is dominated by players such as Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), and Zephyr Surgical Implants (Switzerland).

Scope of the Erectile Dysfunction Devices Industry

Report Metric 

Details 

Market Revenue in 2023

$1.7 billion

Projected Revenue by 2028

$2.7 billion

Revenue Rate

Poised to Grow at a CAGR of 8.8%

Market Driver

Increase in prevalence of prostate cancer

Market Opportunity

Technological advancement

This research report categorizes the Erectile dysfunction devices market to forecast revenue and analyze trends in each of the following submarkets:

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Type

  • Vacuum Constriction Devices
  • Penile Implants
  • Shockwave Therapy
  • Other Device Types

By Age Group

  • Less than 40 years
  • 40-60 years
  • More than 60 years

By Cause

  • Vascular Disorders and Diabetes
  • Neurological Disorders
  • Other Causes

By End User

  • Hospitals and ASCs
  • Clinics

Recent Developments of Erectile Dysfunction Devices Industry

  • In 2023, Rigicon, Inc. (US) introduced the HL-LEVINE Combo Prosthesis Tool, which is a combination of the HL dilator tool and the traditional Furlow instrument, which are both used for penile implant surgery.
  • In 2022, Advanced MedTech Holdings (Singapore) acquired Shenzhen Huikang Medical Apparatus Co., Ltd. (China). This acquisition expanded Advanced MedTech’s urological market access in China via a comprehensive nationwide sales and service network and an established local R&D, manufacturing, and supply chain ecosystem.
  • In 2022, Wikkon’s extracorporeal shock wave lithotripter, model HK.ESWL-108A was successfully installed at Maria Clinic, Dili, East Timor.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 26)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
          FIGURE 1 ERECTILE DYSFUNCTION DEVICES MARKET: MARKET SEGMENTATION
          FIGURE 2 ERECTILE DYSFUNCTION DEVICES INDUSTRY: REGIONAL SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 
 
2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA 
          FIGURE 3 MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    TABLE 1 KEY DATA FROM PRIMARY SOURCES
                    FIGURE 4 KEY INDUSTRY INSIGHTS
                    2.1.2.1 Breakdown of primary interviews
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 7 BOTTOM-UP APPROACH: PATIENT-BASED APPROACH
          FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 9 MARKET: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 IMPACT OF RECESSION 
 
3 EXECUTIVE SUMMARY (Page No. - 41)
    FIGURE 11 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD BILLION)
    FIGURE 12 ERECTILE DYSFUNCTION DEVICES INDUSTRY, BY AGE GROUP, 2023 VS. 2028 (USD BILLION)
    FIGURE 13 MARKET, BY CAUSE, 2023 VS. 2028 (USD BILLION)
    FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
    FIGURE 15 REGIONAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 MARKET OVERVIEW 
          FIGURE 16 INCREASING PREVALENCE OF PROSTATE CANCER TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: MARKET, BY TYPE (2022) 
          FIGURE 17 PENILE IMPLANTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
    4.3 REGIONAL GROWTH OPPORTUNITIES IN MARKET 
          FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET: REGIONAL MIX 
          FIGURE 19 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 20 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 49)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 ERECTILE DYSFUNCTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of prostate cancer
                    5.2.1.2 Growing incidence of diabetes, kidney and liver diseases, and atherosclerosis
                    5.2.1.3 High prevalence of tobacco smoking
                    5.2.1.4 Increasing research and development activities
           5.2.2 RESTRAINTS
                    5.2.2.1 Presence of alternative drug treatments
                    5.2.2.2 Risks associated with use of erectile dysfunction devices
                    5.2.2.3 High cost and lack of reimbursement policies for erectile dysfunction devices
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Technological advancements
                    5.2.3.2 Rising investments and grants
                    5.2.3.3 Expanding market opportunities in emerging countries
           5.2.4 CHALLENGES
                    5.2.4.1 Survival of small players and new entrants
                    5.2.4.2 Low awareness regarding prostate health among men
                    5.2.4.3 Shortage of skilled urologists
    5.3 PRICING ANALYSIS 
          TABLE 2 AVERAGE SELLING PRICE OF DEVICES OFFERED BY KEY PLAYERS
    5.4 PATENT ANALYSIS 
          FIGURE 22 PATENT ANALYSIS FOR PENILE IMPLANTS (JANUARY 2013–DECEMBER 2022)
          TABLE 3 LIST OF KEY PATENTS
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 23 VALUE CHAIN ANALYSIS OF ERECTILE DYSFUNCTION DEVICES INDUSTRY
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 24 MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 25 MARKET: ECOSYSTEM ANALYSIS
           5.7.1 MARKET: ROLE IN ECOSYSTEM
                    FIGURE 26 KEY PLAYERS IN MARKET
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 PORTER’S FIVE FORCES ANALYSIS: MARKET
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 REGULATORY ANALYSIS 
           5.9.1 NORTH AMERICA
                    5.9.1.1 US
                                TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
                    5.9.1.2 Canada
                                TABLE 6 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.9.2 EUROPE
           5.9.3 ASIA PACIFIC
                    5.9.3.1 Japan
                                TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.9.3.2 China
                                TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.9.3.3 India
    5.10 TRADE ANALYSIS 
           TABLE 9 IMPORT DATA FOR MECHANO-THERAPY APPLIANCES, MASSAGE APPARATUS, AND PSYCHOLOGICAL APTITUDE-TESTING APPARATUS, BY COUNTRY, 2018–2022 (USD MILLION)
           TABLE 10 EXPORT DATA FOR MECHANO-THERAPY APPLIANCES, MASSAGE APPARATUS, AND PSYCHOLOGICAL APTITUDE-TESTING APPARATUS, BY COUNTRY, 2018–2022 (USD MILLION)
    5.11 TECHNOLOGY ANALYSIS 
    5.12 KEY CONFERENCES AND EVENTS IN 2023–2024 
           TABLE 11 MARKET: LIST OF KEY CONFERENCES AND EVENTS
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 27 REVENUE SHIFT IN MARKET
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ERECTILE DYSFUNCTION DEVICES
                     TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ERECTILE DYSFUNCTION DEVICES
           5.14.2 BUYING CRITERIA
                     FIGURE 29 KEY BUYING CRITERIA FOR ERECTILE DYSFUNCTION DEVICES
                    TABLE 13 KEY BUYING CRITERIA FOR ERECTILE DYSFUNCTION DEVICES
 
6 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE (Page No. - 70)
    6.1 INTRODUCTION 
          TABLE 14 ERECTILE DYSFUNCTION DEVICES INDUSTRY, BY TYPE, 2021–2028 (USD MILLION)
    6.2 PENILE IMPLANTS 
          TABLE 15 PENILE IMPLANTS: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 16 PENILE IMPLANTS: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.1 INFLATABLE IMPLANTS
                    6.2.1.1 Spontaneity of inflatable implants to drive growth
                                TABLE 17 INFLATABLE PENILE IMPLANTS OFFERED BY MARKET PLAYERS
                                TABLE 18 INFLATABLE PENILE IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.2 MALLEABLE IMPLANTS
                    6.2.2.1 Low maintenance and affordability to drive growth
                                TABLE 19 MALLEABLE PENILE IMPLANTS OFFERED BY MARKET PLAYERS
                                TABLE 20 MALLEABLE PENILE IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.3 VACUUM CONSTRICTION DEVICES 
           6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE GROWTH
                    TABLE 21 VACUUM CONSTRICTION DEVICES OFFERED BY MARKET PLAYERS
                    TABLE 22 VACUUM CONSTRICTION DEVICES: MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.4 SHOCKWAVE THERAPY 
           6.4.1 NON-INVASIVE NATURE OF TREATMENT TO DRIVE GROWTH
                    TABLE 23 SHOCKWAVE THERAPY PRODUCTS OFFERED BY MARKET PLAYERS
                    TABLE 24 SHOCKWAVE THERAPY: MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.5 OTHER DEVICE TYPES 
          TABLE 25 OTHER DEVICE TYPES OFFERED BY MARKET PLAYERS
          TABLE 26 OTHER DEVICE TYPES: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
7 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP (Page No. - 78)
    7.1 INTRODUCTION 
          TABLE 27 MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
    7.2 LESS THAN 40 YEARS 
           7.2.1 INCREASE IN TOBACCO SMOKING TO DRIVE MARKET
                    TABLE 28 LESS THAN 40 YEARS: MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.3 40–60 YEARS 
           7.3.1 INCREASING PREVALENCE OF CVD TO DRIVE GROWTH
                    TABLE 29 40–60 YEARS: MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.4 MORE THAN 60 YEARS 
           7.4.1 HIGH PREVALENCE OF VASCULAR DISORDERS TO DRIVE GROWTH
                    TABLE 30 MORE THAN 60 YEARS: MARKET, BY REGION, 2021–2028 (USD MILLION)

8 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE (Page No. - 82)
    8.1 INTRODUCTION 
          TABLE 31 ERECTILE DYSFUNCTION DEVICES INDUSTRY, BY CAUSE, 2021–2028 (USD MILLION)
    8.2 VASCULAR DISORDERS AND DIABETES 
           8.2.1 VASCULAR DISORDERS AND DIABETES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
                    TABLE 32 VASCULAR DISORDERS AND DIABETES: MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.3 NEUROLOGICAL DISORDERS 
           8.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE GROWTH
                    TABLE 33 NEUROLOGICAL DISORDERS: MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.4 OTHER CAUSES 
          TABLE 34 OTHER CAUSES: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
9 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER (Page No. - 87)
    9.1 INTRODUCTION 
          TABLE 35 MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.2 HOSPITALS AND ASCS 
           9.2.1 AVAILABILITY OF REIMBURSEMENT AND MULTIDISCIPLINARY CARE IN HOSPITALS TO DRIVE GROWTH
TABLE 36 HOSPITALS AND ASCS: MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.3 CLINICS 
           9.3.1 CLINICS SEGMENT TO HOLD LARGER MARKET SHARE
TABLE 37 CLINICS: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
10 ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION (Page No. - 91)
     10.1 INTRODUCTION 
             TABLE 38 ERECTILE DYSFUNCTION DEVICES INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 39 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 40 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 41 NORTH AMERICA: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 42 NORTH AMERICA: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
             TABLE 43 NORTH AMERICA: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
             TABLE 44 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.1 NORTH AMERICA: RECESSION IMPACT
             10.2.2 US
                        10.2.2.1 US held largest share of North American market in 2022
                                      TABLE 45 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 46 US: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 47 US: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 48 US: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 49 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Growing government investments and continuous technological developments to drive growth
                                      TABLE 50 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 51 CANADA: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 52 CANADA: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 53 CANADA: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 54 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
                        TABLE 55 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 56 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 57 EUROPE: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 58 EUROPE: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                        TABLE 59 EUROPE: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                        TABLE 60 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 Germany to dominate European market during forecast period
                                      TABLE 61 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 62 GERMANY: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 63 GERMANY: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 64 GERMANY: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 65 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Favorable government initiatives to support growth
                                      TABLE 66 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 67 FRANCE: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 68 FRANCE: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 69 FRANCE: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 70 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 UK
                        10.3.4.1 Rising incidence of kidney disorders to drive growth
                                      TABLE 71 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 72 UK: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 73 UK: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 74 UK: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 75 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Aging population to drive growth
                                      TABLE 76 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 77 ITALY: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 78 ITALY: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 79 ITALY: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 80 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Growing awareness of ED to drive growth
                                      TABLE 81 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 82 SPAIN: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 83 SPAIN: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 84 SPAIN: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 85 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 86 REST OF EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 87 REST OF EUROPE: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 88 REST OF EUROPE: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                        TABLE 89 REST OF EUROPE: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                        TABLE 90 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 31 ASIA PACIFIC: MARKET SNAPSHOT
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                        TABLE 91 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 92 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 93 ASIA PACIFIC: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 94 ASIA PACIFIC: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                        TABLE 95 ASIA PACIFIC: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                        TABLE 96 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Japan to hold largest share of Asia Pacific market
                                      TABLE 97 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 98 JAPAN: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 99 JAPAN: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 100 JAPAN: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 101 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 CHINA
                        10.4.3.1 China to register highest growth in Asia Pacific market during forecast period
                                      TABLE 102 CHINA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 103 CHINA: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 104 CHINA: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 105 CHINA: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 106 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Favorable government initiatives to drive growth
                                      TABLE 107 INDIA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 108 INDIA: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 109 INDIA: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 110 INDIA: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 111 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 112 ROAPAC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 113 ROAPAC: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 114 ROAPAC: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                        TABLE 115 ROAPAC: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                        TABLE 116 ROAPAC: MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.5 REST OF THE WORLD 
             10.5.1 REST OF THE WORLD: RECESSION IMPACT
                        TABLE 117 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 118 REST OF THE WORLD: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 119 REST OF THE WORLD: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 120 REST OF THE WORLD: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                        TABLE 121 REST OF THE WORLD: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                        TABLE 122 REST OF THE WORLD: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 LATIN AMERICA
                        10.5.2.1 High prevalence of chronic diseases to drive growth
                                      TABLE 123 LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 124 LATIN AMERICA: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 125 LATIN AMERICA: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 126 LATIN AMERICA: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 127 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.3 MIDDLE EAST & AFRICA
                        10.5.3.1 Increasing healthcare spending to drive growth
                                      TABLE 128 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 129 MIDDLE EAST & AFRICA: MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 130 MIDDLE EAST & AFRICA: MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
                                      TABLE 131 MIDDLE EAST & AFRICA: MARKET, BY CAUSE, 2021–2028 (USD MILLION)
                                      TABLE 132 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 134)
     11.1 OVERVIEW 
     11.2 MARKET SHARE ANALYSIS 
             TABLE 133 ERECTILE DYSFUNCTION DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
     11.3 COMPANY EVALUATION MATRIX (2022) 
             11.3.1 STARS
             11.3.2 EMERGING LEADERS
             11.3.3 PERVASIVE PLAYERS
             11.3.4 PARTICIPANTS
                        FIGURE 32 MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
     11.4 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 
             11.4.1 PROGRESSIVE COMPANIES
             11.4.2 STARTING BLOCKS
             11.4.3 RESPONSIVE COMPANIES
             11.4.4 DYNAMIC COMPANIES
                        FIGURE 33 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     11.5 COMPETITIVE BENCHMARKING 
             TABLE 134 MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 135 PRODUCT FOOTPRINT OF KEY PLAYERS
             TABLE 136 REGIONAL FOOTPRINT OF KEY PLAYERS
             TABLE 137 MARKET: LIST OF KEY START-UPS/SMES
     11.6 COMPETITIVE SCENARIO 
             11.6.1 KEY PRODUCT LAUNCHES
                        TABLE 138 KEY PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
             11.6.2 KEY DEALS
                        TABLE 139 KEY DEALS, JANUARY 2020–JUNE 2023
             11.6.3 OTHER KEY DEVELOPMENTS
                        TABLE 140 OTHER KEY DEVELOPMENTS, JANUARY 2020–JUNE 2023
 
12 COMPANY PROFILES (Page No. - 145)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     12.1 KEY PLAYERS 
             12.1.1 BOSTON SCIENTIFIC CORPORATION
                        TABLE 141 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
                        FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.2 COLOPLAST GROUP
                        TABLE 142 COLOPLAST GROUP: COMPANY OVERVIEW
                        FIGURE 35 COLOPLAST GROUP: COMPANY SNAPSHOT (2022)
             12.1.3 RIGICON, INC.
                        TABLE 143 RIGICON, INC.: COMPANY OVERVIEW
                        TABLE 144 RIGICON, INC.: PRODUCT LAUNCHES
             12.1.4 PROMEDON GMBH
                        TABLE 145 PROMEDON GMBH: COMPANY OVERVIEW
             12.1.5 ZEPHYR SURGICAL IMPLANTS
                        TABLE 146 ZEPHYR SURGICAL IMPLANTS: COMPANY OVERVIEW
             12.1.6 OWEN MUMFORD LTD.
                        TABLE 147 OWEN MUMFORD LTD.: COMPANY OVERVIEW
                        TABLE 148 OWEN MUMFORD LTD.: OTHER DEVELOPMENTS
             12.1.7 AUGUSTA MEDICAL SYSTEMS LLC
                        TABLE 149 AUGUSTA MEDICAL SYSTEMS LLC: COMPANY OVERVIEW
             12.1.8 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.
                        TABLE 150 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: COMPANY OVERVIEW
                        TABLE 151 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: DEALS
                        TABLE 152 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: OTHER DEVELOPMENTS
             12.1.9 ZIMMER MEDIZINSYSTEME GMBH
                        TABLE 153 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
             12.1.10 MEDISPEC LTD.
                        TABLE 154 MEDISPEC LTD.: COMPANY OVERVIEW
             12.1.11 MTS MEDICAL UG
                        TABLE 155 MTS MEDICAL UG: COMPANY OVERVIEW
                        TABLE 156 MTS MEDICAL UG: DEALS
     12.2 OTHER PLAYERS 
             12.2.1 NOVAMEDTEK
             12.2.2 STORZ MEDICAL AG
             12.2.3 THE ELATOR
             12.2.4 TIMM MEDICAL
             12.2.5 OHH-MED MEDICAL LTD.
             12.2.6 COMPHYA SA
             12.2.7 DIREXGROUP
             12.2.8 ADVIN HEALTH CARE
             12.2.9 GIDDY
             12.2.10 GLOBAL LIFE TECHNOLOGIES LTD.
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 170)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the erectile dysfunction devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals and research institutes) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, and Rest of the World. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Erectile Dysfunction Devices Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various erectile dysfunction devices were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value erectile dysfunction devices market was also split into various segments and subsegments at the region and country level based on the:

  • Product mapping of various manufacturers for each type of market at the regional and country-level 
  • Relative adoption pattern of each market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Bottom-Up Approach: Patient-Based Approach

Erectile Dysfunction Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Erectile dysfunction devices industry.

Market Definition

Erectile dysfunction is defined as the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.  Most men suffer from erectile dysfunction, which is caused by physical problems usually related to the blood supply of the penis. An erectile dysfunction pump is a device used to help achieve and maintain an erection by drawing blood into the penis via air suction. It is not a cure for erectile dysfunction, but it can help increase the ability to have sexual intercourse.

Key Stakeholders

  • Senior Management
  • Finance/Procurement Department
  • Doctors/Technician

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the erectile dysfunction devices market by type, age group, cause, end user, and region.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Rest of the world.
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the market.
  • To benchmark players within the market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Erectile dysfunction devices market
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Erectile dysfunction devices Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
MD 8720
Published ON
Jul, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Erectile Dysfunction Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback